These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1285119)

  • 21. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 22. New guidelines for management and prevention of meningococcal disease in Australia. Meningococcal Disease Working Party of the National Health and Medical Research Council.
    Patel MS; Collignon PJ; Watson CR; Condon RJ; Doherty RR; Merianos A; Stewart GJ
    Med J Aust; 1997 Jun; 166(11):598-601. PubMed ID: 9201182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Meningococcal disease. new prevention strategies].
    Soult Rubio JA; Muñoz Sáez M; López Castilla JD
    An Esp Pediatr; 2001 Jan; 54(1):65-8. PubMed ID: 11181197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccine prevention of meningococcal disease: making slow progress.
    Harrison LH
    Clin Infect Dis; 2006 Dec; 43(11):1395-7. PubMed ID: 17083010
    [No Abstract]   [Full Text] [Related]  

  • 28. Severe outbreak of meningococcal disease in Auckland.
    Jackson G; Lennon D; Voss L; Flight R
    N Z Med J; 1987 Apr; 100(821):226. PubMed ID: 3455492
    [No Abstract]   [Full Text] [Related]  

  • 29. Meningococcal infections in England and Wales: report of the Meningococcal Reference Laboratory for 1990.
    Jones DM; Kaczmarski EB
    CDR (Lond Engl Rev); 1991 Jun; 1(7):R76-8. PubMed ID: 1669781
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for control of meningococcal disease. The Advisory Committee on Epidemiology.
    Can Dis Wkly Rep; 1991 Nov; 17(45):245-50. PubMed ID: 1843653
    [No Abstract]   [Full Text] [Related]  

  • 31. PHLS overview of communicable diseases 1997: results of a priority setting exercise.
    Rushdy A; O'Mahony M
    Commun Dis Rep CDR Suppl; 1998 Nov; 8(5):S1-12. PubMed ID: 9830790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningococcal disease in Delhi.
    Taneja A
    Indian Pediatr; 1985 Mar; 22(3):181-4. PubMed ID: 4030053
    [No Abstract]   [Full Text] [Related]  

  • 33. Epidemiology of meningococcal disease and a community outbreak in Somerset.
    Gunnell DJ; Pearson N; Ley B; Hill A
    Commun Dis Rep CDR Rev; 1994 Aug; 4(9):R101-4. PubMed ID: 7522806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity of meningococcal disease associated with genomic bacterial load.
    Darton T; Guiver M; Naylor S; Jack DL; Kaczmarski EB; Borrow R; Read RC
    Clin Infect Dis; 2009 Mar; 48(5):587-94. PubMed ID: 19191644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for control of meningococcal disease. Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control, Ottawa, Ontario, Canada.
    Can Commun Dis Rep; 1994 Feb; 20(3):17-27. PubMed ID: 8167604
    [No Abstract]   [Full Text] [Related]  

  • 36. [Why and when to vaccinate against meningococcal disease].
    Humble M
    Nord Med; 1984; 99(10):248-50, 253. PubMed ID: 6436785
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemiology and prevention of meningococcal infection].
    Favorova LA; Teleshevskaya EA; Troshina LD; Vinnichek ND; Ershova GA
    Sov Med; 1971 Nov; 34(11):113-8. PubMed ID: 5160619
    [No Abstract]   [Full Text] [Related]  

  • 39. Control of meningococcal disease.
    Begg NT
    Commun Dis Rep CDR Rev; 1992 May; 2(6):R65. PubMed ID: 1285108
    [No Abstract]   [Full Text] [Related]  

  • 40. Deaths from meningococcal infection in England and Wales in 1978.
    Slack J
    J R Coll Physicians Lond; 1982 Jan; 16(1):40-4. PubMed ID: 7062308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.